Bofar SA
6.3 FTEThe score of Bofar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +2 % Total assets +39 % Headcount (avg FTE) -27 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bofar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €23.9m | ||||
| Net result | €2.10m | ||||
| Equity | €4.23m | ||||
| Cash | 661,171 € | ||||
| EBITDA | €2.72m | ||||
| Total assets | €12.2m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 20 Jul 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 07 Oct 2023
- Year ended 31 Dec 2021filed on 28 Aug 2022
Bofar's financial analysis
- Solvency34.8%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bofar
Bofar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0425.935.908
- VAT number
- BE0425935908
- Peppol
- Registered · 0208:0425935908 · as of 08 Nov 2026
- Legal form
- SA
- Incorporated
- 20 Jun 1984
- Registered office
- 8750 Wingene
- Size
- Micro · 6.3 FTE
- Latest accounts
- 2025 · filed on 20 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Bofar (SA) has been based in Wingene since 1984, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €23.9m, a net profit of €2.10m and equity of €4.23m. With 6.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 34.8%, below the median of its sector (46.0%).
Companies similar to Bofar
Companies in the same business, of comparable size and area, outside its group.
- URGO Activities of agents involved in non-specialised wholesale Uccle · balance sheet €17.1m
- Accord Healthcare Wholesale of pharmaceutical and medical goods Brussels · balance sheet €10.5m
- S.A Therabel-Pharma N.V. Wholesale of pharmaceutical and medical goods Forest · balance sheet €12.8m
- Ceres Pharmaceuticals Wholesale of pharmaceutical and medical goods Ghent · balance sheet €9.46m
- Elekta Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €13.1m
- Norgine Wholesale of pharmaceutical and medical goods Leuven · balance sheet €14.1m
- ixX pharma Wholesale of pharmaceutical and medical goods Antwerp · balance sheet €11.3m
- BIOCODEX Benelux Wholesale of pharmaceutical and medical goods Forest · balance sheet €8.15m
Frequently asked questions about Bofar
What is the revenue of Bofar?
According to the 2025 annual accounts filed with the NBB, the revenue of Bofar amounts to 23,919,445 €.
What is the VAT number of Bofar?
In Belgium, the VAT number is the company number prefixed with BE: BE0425935908 for Bofar, if the company is VAT-registered. Its company number (CBE) is 0425.935.908.
Where is the registered office of Bofar?
According to the CBE register, the registered office of Bofar is in 8750 Wingene.
What is the equity of Bofar?
At the close of the 2025 financial year, the equity of Bofar amounts to 4,226,018 €, a solvency of 34.8% of total assets.
How many people work at Bofar?
6.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Bofar?
The register lists 6 active mandates at Bofar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Bofar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →